During the last three months, 8 analysts shared their evaluations of Lexicon Pharmaceuticals LXRX, revealing diverse outlooks from bullish to bearish. The following table provides a quick overview ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback